维普期刊资源整合服务平台（V6.5）

31篇 您的检索式：作者名="Ulrichts"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	How does agkicetin-C bind on platelet gl ycoprotein Ibalpha and achieve its platelet effects 显示文摘	Xu G Ulrichts H Vauterin S	2005	Toxicon2005，45，：	1
2	MAPPTT analysis of TLR adaptor complexes显示文摘	Peelma F Beyaert R	2007	FEBS Lett2007，581，4：	1
3	The GPIbα-thrombin interaction:far from crystal clear显示文摘	Vanhoorelbeke K Ulrichts H Romijn RA		0，，：	1
4	Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared to currently marketed antiplatelet drugs显示文摘	Ulrichts H Silence K Schoolmeester A		0，，：	1
5	Inhibition of platelet glycoprotein Ib and its antithrombotic potential显示文摘	Vanhoorelbeke K Ulrichts H de Walle GV		0，，：	1
6	Inhibition of platelet adhesion to collagen as a new target for antithrombotic drugs显示文摘	Vanhoorelbeke K Ulrichts H Schoolmeester A	2003	Curr Drug Targets Cardiovasc Haematol Disrod2003，3，2：	1
7	Inhibition of platelet adhesion to collagen as a new target for antithrombotic drugs显示文摘	Vanhoorelbeke K Ulrichts H Schoohneester A	2003	Curr Drug Targets Cardiovase HaematolDisrod2003，3，2：	1
8	Inhibition of platelet adhesion to collage as a new larget for antihrombotic drugs显示文摘	ULRICHTS H SCHOOHNEESTER A	2003	Curr Durg Targets Cardiovase HAematol Disrod2003，3，2：	1
9	von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ⅰ bα is influenced by the HPA-2 polymorphism 显示文摘	Ulrichts H Vanhoorelbeke K Cauwenberghs S	2003	Arterioscler Thromb Vasc Biol2003，23，7：	1
10	Inhihition of platelet adhesion to collagen as a new target for anti thrombotic drugs 显示文摘	V A NHOORELHEKE K ULRICHTS H SCHOOLMEESTER A	2003	Curr lJrug Targets Cardiovasc Haemaiol Disord2003，3，2：	1
11	The in vitro effect of the new antithromhotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary in-tervention显示文摘	VAN LOON J E DE JAEGERE P P ULRICHTS H	2011	ThrombHaemosl2011，106，1：	1
12	An-tithrombotio drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs显示文摘	ULRICHTS H SILENCE K SCHOOLMEESTER A	2011	Blood2011，118，3：	1
13	Caspase- 1 targets the TLR adaptor Mal at a crucial TIR-domain in- teraction site显示文摘	ULRICHTS P BOVILIN C LIEVENS S	2010	J Cell Sci2010，123，2：	1
14	MAPPIT (mammalian protein-protein interaction trap) analysis of early steps in toll-like receptor signalling 显示文摘	Ulrichts P Lemmens I Lavens D	2009	Methods Mol Biol2009，517，：	1
15	Inhibition of platelet adhesion to collagen as a new target for antithrombotic drugs显示文摘	Vanhoorelbeke K Ulrichts H Schoohneester A	2003	Curr Drug Targets Cardiovase Haematol Disrod2003，3，2：	1
16	The GPIba thrombin interaction:far from crystal clear显示文摘	Vanhoorelbeke K Ulrichts H Romijn RA	2004	TRENDS in Molecular Medicine2004，10，：	1
17	MAPPIT analysis of early Toll-like receptor signalling events显示文摘	Ulrichts P Tavernier J	2008	Immunol Letters2008，116，2：	1
18	Antithromboticdrug candidate ALX - 0081 shows superior preclinical efficacy andsafety compared with currently marketed antiplatelet drugs 显示文摘	Ulrichts H Silence K Schoolmeester A	2011	Blood2011，118，3：	1
19	Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba 显示文摘	Pontiggia L Steiner B Ulrichts H	2006	Thromb and Haemost2006，96，6：	1
20	Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura显示文摘	Callewaert F Roodt J Ulrichts H	2012	{H}Blood2012，，17：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示